Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
ACS and CAD Treatment | BRILINTA® (ticagrelor) tablets | for HCPs
BRILINTA® (ticagrelor) is an oral prescription indicated for treatment of coronary artery disease and acute coronary syndrome.
This website is hosted with Corporation Service Company, which reserves the following IP addresses for brilintatouchpoints.com: 165.160.13.20, 165.160.15.20. Moreover, DNS used with this website include dns1.cscdns.net, dns2.cscdns.net. Subnet identifier ranges from 165.160.0.0 to 165.160.255.255. Classless Inter-Domain Routing (CIDR) is 165.160.0.0/16. ARIN net type is Direct Allocation.
Last scanned
Domain Age
Daily Visitors
Global Rank
dns1.cscdns.net
dns2.cscdns.net
{{value}}
2009-10-15
2023-10-15
CSC CORPORATE DOMAINS, INC.
{{value}}
The registrar of brilintatouchpoints.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2023-10-15. According to open source data, you can reach the owner at domains@astrazeneca.com but please make sure you have a good reason for unsolicited messages. Their country of residence is Sweden.
Oct 27, 2016
Sep 15, 2017
Oct 15, 2018
Feb 14, 2020
N/A
89
N/A
267
N/A
N/A
N/A
N/A
N/A
N/A